BACKGROUND Previous studies have proved that intracoronary injection of eptifibatide is
safe and more effective in infarct size reduction and clinical outcomes than intravenously …

Aim: To compare the outcomes of intracoronary (IC) and intravenous (IV) administration of
eptifibatide during primary percutaneous coronary intervention (PPCI) in patients with ST …

Background. Eptifibatide achieves high local concentration via direct intracoronary (I/V)
injection as it promotes clot disaggregation, but it remains unclear if it is of superior benefit …

Although aspirin and clopidogrel seem to be quite enough during low risk percutaneous
coronary intervention (PCI), the combination may need some reinforcement in complex …

Intracoronary bolus of eptifibatide during percutaneous coronary intervention (PCI) for acute
myocardial infarction (AMI) has been shown to result in higher local platelet glycoprotein …

Background Facilitation therapy in ST-elevation myocardial infarction (STEMI) is still
controversial and no relationship between timing of treatment and efficacy has been …

Background: Despite the benefits of primary percutaneous coronary intervention (PPCI),
myocardial perfusion after treatment remains disrupted in some patients. The utility of …

Background Primary percutaneous coronary intervention (PCI) in patients with acute
myocardial infarction (AMI) has been shown to be the preferred reperfusion strategy …

Background—Eptifibatide reduces major adverse cardiac events in patients with acute
coronary syndromes undergoing percutaneous coronary intervention (PCI). Intracoronary …

Distal embolization of atherothrombotic material during primary percutaneous coronary
intervention (PCI) is associated with impaired myocardial perfusion, abnormal left ventricular …